Ozempic and opioid medications can both slow gastrointestinal motility. Learn how this combination may increase nausea, bloating, delayed gastric emptying, and the risk of digestive complications.
Ozempic commonly causes nausea, fullness, and appetite suppression, but similar symptoms can also occur with gastroparesis. Learn the warning signs that help distinguish routine digestive side effects from a potentially serious gastric emptying disorder.
Rapid weight loss is often viewed as proof that GLP-1 medications are working. But in some cases, worsening nausea, extreme fullness, and food intolerance may signal gastroparesis rather than successful appetite control.
GLP-1 medications such as Ozempic and Wegovy intentionally slow digestion, but in rare cases this effect can progress to gastroparesis. Learn how to recognize warning signs, understand risk factors, and know when medical evaluation is necessary.
Constipation is a common yet overlooked side effect of GLP-1 medications like semaglutide. Learn why it happens, how to prevent it, and when it may signal something more serious.
This guide explains how GLP-1 drugs work, their benefits, side effects, and safety considerations for diabetes and weight management in the U.S. and Canada.